Overall survival graft versus. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Saphenous Vein Cell Line, Tumor Transplants Veins Lymph Nodes Femoral Artery Neoplastic Cells, Circulating Jugular Veins Cells, Cultured

Organisms1

Mice, Inbred C57BL

Diseases68

Graft Occlusion, Vascular Neoplasm Recurrence, Local Breast Neoplasms Lung Neoplasms Neoplasm Metastasis Adenocarcinoma Disease Progression Lymphatic Metastasis Recurrence Liver Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Brain Neoplasms Carcinoma, Squamous Cell Ovarian Neoplasms Graft vs Host Disease Multiple Myeloma Carcinoma Postoperative Complications Carcinoma, Hepatocellular Leukemia, Myeloid, Acute Stomach Neoplasms Lymphoma, Large B-Cell, Diffuse Bone Neoplasms Melanoma Neoplasm Invasiveness Pancreatic Neoplasms Head and Neck Neoplasms Glioblastoma Kidney Neoplasms Esophageal Neoplasms Hodgkin Disease Lymphoma, Non-Hodgkin Sarcoma Carcinoma, Renal Cell Primary Graft Dysfunction Lymphoma, Follicular Nasopharyngeal Neoplasms Skin Neoplasms Rectal Neoplasms Central Nervous System Neoplasms Prostatic Neoplasms Neoplasms, Glandular and Epithelial Precursor Cell Lymphoblastic Leukemia-Lymphoma Peritoneal Neoplasms Neoplasm, Residual Leukemia, Lymphocytic, Chronic, B-Cell Glioma Myelodysplastic Syndromes Osteosarcoma Soft Tissue Neoplasms Neoplasms Acute Disease Neutropenia Urinary Bladder Neoplasms Oropharyngeal Neoplasms Cadaver Cystadenocarcinoma, Serous Neoplastic Cells, Circulating Lymphoma, B-Cell Disease Models, Animal Hematologic Neoplasms Colonic Neoplasms Leukemia, Myeloid Neoplasms, Second Primary Carcinoma, Ductal, Breast Small Cell Lung Carcinoma Carcinoma, Transitional Cell

Chemicals and Drugs62

Tumor Markers, Biological Antineoplastic Agents Fluorouracil Cisplatin Cyclophosphamide Vincristine Doxorubicin Deoxycytidine Prednisone Polytetrafluoroethylene Antibodies, Monoclonal, Humanized Organoplatinum Compounds Etoposide Leucovorin Taxoids Dacarbazine Antimetabolites, Antineoplastic Paclitaxel Carboplatin Vinblastine Antibodies, Monoclonal Cytarabine Methotrexate Polyethylene Terephthalates Camptothecin Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Receptor, erbB-2 Melphalan Immunosuppressive Agents Bleomycin Procarbazine Thalidomide Epirubicin Antineoplastic Agents, Hormonal Anthracyclines Platinum Compounds Niacinamide Ifosfamide Receptors, Estrogen Quinazolines Phenylurea Compounds Receptors, Progesterone Mitoxantrone Neoplasm Proteins Ki-67 Antigen Benzenesulfonates Protein Kinase Inhibitors Tamoxifen Receptor, Epidermal Growth Factor RNA, Messenger Antineoplastic Agents, Phytogenic Vidarabine Tumor Suppressor Protein p53 Mechlorethamine Carmustine Angiogenesis Inhibitors Lomustine Tegafur Daunorubicin Proto-Oncogene Proteins Interferon-alpha

Analytical, Diagnostic and Therapeutic Techniques and Equipment97

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Prognosis Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Neoplasm Staging Combined Modality Therapy Follow-Up Studies Proportional Hazards Models Chemotherapy, Adjuvant Multivariate Analysis Immunohistochemistry Blood Vessel Prosthesis Drug Administration Schedule Prospective Studies Remission Induction Transplantation, Autologous Radiotherapy, Adjuvant Risk Factors Salvage Therapy Neoadjuvant Therapy Predictive Value of Tests Cohort Studies Kidney Transplantation Chemoradiotherapy Liver Transplantation Hematopoietic Stem Cell Transplantation Risk Assessment Radiotherapy Dosage Life Tables Reoperation Neoplasm Grading Clinical Trials, Phase III as Topic Treatment Failure Blood Vessel Prosthesis Implantation Randomized Controlled Trials as Topic Transplantation, Homologous Radiotherapy Dose Fractionation Tissue Array Analysis Transplantation Conditioning Induction Chemotherapy Bone Marrow Transplantation Infusions, Intravenous Hepatectomy Clinical Trials as Topic Coronary Artery Bypass Chi-Square Distribution Registries Lymph Node Excision Stem Cell Transplantation Actuarial Analysis Anastomosis, Surgical Tumor Burden Reverse Transcriptase Polymerase Chain Reaction Heart Transplantation Histocompatibility Testing Clinical Trials, Phase II as Topic Patient Selection Probability Chemoradiotherapy, Adjuvant Analysis of Variance Tomography, X-Ray Computed Immunoenzyme Techniques Gene Expression Profiling Prosthesis Design Cranial Irradiation SEER Program Palliative Care Arteriovenous Shunt, Surgical Incidence Feasibility Studies Karnofsky Performance Status Chemoembolization, Therapeutic Brachytherapy Preoperative Care Radiosurgery Esophagectomy In Situ Hybridization, Fluorescence Multicenter Studies as Topic Cystectomy Statistics, Nonparametric Peripheral Blood Stem Cell Transplantation Radiotherapy, Conformal Nomograms Transplantation, Heterotopic Disease Models, Animal Gastrectomy Maintenance Chemotherapy Reconstructive Surgical Procedures Vascular Surgical Procedures Cause of Death Transplantation, Isogeneic Postoperative Period

Phenomena and Processes14

Graft Survival Cell Survival Time Factors Vascular Patency Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Apoptosis Mutation Chi-Square Distribution Cell Proliferation Dose-Response Relationship, Drug Probability Signal Transduction Nomograms

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Technology, Industry, Agriculture2

Polytetrafluoroethylene Polyethylene Terephthalates

Humanities1

Quality of Life

Information Science7

Survival Rate Life Tables Registries SEER Program Incidence Radiotherapy, Conformal Cause of Death

Named Groups1

Health Care38

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Risk Factors Predictive Value of Tests Cohort Studies Risk Assessment Life Tables Clinical Trials, Phase III as Topic Treatment Failure Age Factors Randomized Controlled Trials as Topic Clinical Trials as Topic Chi-Square Distribution Registries Actuarial Analysis Clinical Trials, Phase II as Topic Patient Selection Probability Analysis of Variance SEER Program Palliative Care Incidence Feasibility Studies Karnofsky Performance Status Preoperative Care Multicenter Studies as Topic Statistics, Nonparametric Nomograms Cause of Death Postoperative Period

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care

Survival Rate Graft Survival Disease-Free Survival Survival Analysis Treatment Outcome Prognosis Cell Survival Kaplan-Meier Estimate Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Neoplasm Staging Graft Occlusion, Vascular Combined Modality Therapy Follow-Up Studies Survival Neoplasm Recurrence, Local Time Factors Proportional Hazards Models Chemotherapy, Adjuvant Tumor Markers, Biological Antineoplastic Agents Breast Neoplasms Fluorouracil Lung Neoplasms Multivariate Analysis Neoplasm Metastasis Cisplatin Cyclophosphamide Adenocarcinoma Vincristine Disease Progression Doxorubicin Immunohistochemistry Blood Vessel Prosthesis Drug Administration Schedule Lymphatic Metastasis Recurrence Prospective Studies Remission Induction Transplantation, Autologous Radiotherapy, Adjuvant Deoxycytidine Liver Neoplasms Prednisone Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Polytetrafluoroethylene Brain Neoplasms Carcinoma, Squamous Cell Risk Factors Salvage Therapy Neoadjuvant Therapy Predictive Value of Tests Antibodies, Monoclonal, Humanized Cohort Studies Ovarian Neoplasms Organoplatinum Compounds Kidney Transplantation Etoposide Graft vs Host Disease Chemoradiotherapy Liver Transplantation Hematopoietic Stem Cell Transplantation Leucovorin Taxoids Dacarbazine Antimetabolites, Antineoplastic Risk Assessment Multiple Myeloma Carcinoma Paclitaxel Vascular Patency Postoperative Complications Carboplatin Radiotherapy Dosage Life Tables Carcinoma, Hepatocellular Gene Expression Regulation, Neoplastic Vinblastine Leukemia, Myeloid, Acute Reoperation Stomach Neoplasms Neoplasm Grading Antibodies, Monoclonal Clinical Trials, Phase III as Topic Treatment Failure Age Factors Blood Vessel Prosthesis Implantation Randomized Controlled Trials as Topic Lymphoma, Large B-Cell, Diffuse Cytarabine Bone Neoplasms Melanoma Neoplasm Invasiveness Transplantation, Homologous Radiotherapy Pancreatic Neoplasms Methotrexate Polyethylene Terephthalates Saphenous Vein

No FAQ available that match "overall survival graft versus"